-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Buy on Gilead Sciences, Raises Price Target to $145

Benzinga·11/03/2025 15:23:56
Listen to the news
Truist Securities analyst Asthika Goonewardene reiterates Gilead Sciences (NASDAQ:GILD) with a Buy and raises the price target from $127 to $145.